Article

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

2020-09-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Since 1920, a decrease in serum cholesterol has been identified as a marker of severe pneumonia. We have assessed the performance of serum apolipoprotein-A1, the main transporter of HDL-cholesterol, to identify the early spread of coronavirus disease 2019 (Covid-19) in the general population and its diagnostic performance for the Covid-19. <h4>Methods</h4> We compared the dail...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 59158c69-f5a8-5b8b-9515-e7a38f57791c
DOI: 10.1101/2020.09.01.20186213

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19DOI 10.1101/2020.09.01.20186213Read

Low serum apolipoprotein A 1 is an indicator of severity in patients with coronavirus disease 2019Semantic proximity Read

Low serum level of apolipoprotein A1 is an indicator of severity in patients with coronavirus disease 2019Semantic proximity Read

A case-control Study on Blood Lipid Profile in Patients with COVID-19Semantic proximity Read

Apolipoprotein E4 Allele in Subjects with COVID-19Semantic proximity Read

Metabolic indicators associated with non-communicable diseases deteriorated in the Coronavirus Disease 2019 outbreak: evidence from a two-center, retrospective, self-controlled studySemantic proximity Read

Changes in cardiovascular disease monitoring in English primary care during the COVID-19 pandemic: an observational cohort studySemantic proximity Read

Cohort profile: 10K - a large-scale prospective longitudinal study in IsraelSemantic proximity Read

Association of serum HDL-cholesterol and apolipoprotein A1 levels with risk of severe SARS-CoV-2 infectionSemantic proximity Read

NON-WHITE ETHNICITY, MALE SEX, AND HIGHER BODY MASS INDEX, BUT NOT MEDICATIONS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM ARE ASSOCIATED WITH CORONAVIRUS DISEASE 2019 (COVID-19) HOSPITALISATION: REVIEW OF THE FIRST 669 CASES FROM THE UK BIOBANKSemantic proximity Read

The COVID-19 pandemic and temporal change in metabolic risk factors for cardiovascular disease: a natural experiment within the HELIUS studySemantic proximity Read

APOSCREEN-1 – a prospective implementation study for pharmacy-based screening for cardiovascular-kidney-metabolic risk factors in Schleswig-HolsteinSemantic proximity Read

Seroprevalence against COVID-19 and follow-up of suspected cases in primary health care in SpainSemantic proximity Read